Rossouw JE, Lewis B, Rifkind BM: The value of lowering cholesterol after myocardial infarction. N Engl J Med. 323 (16): 1112-9. 1990 Oct 18,
Vita JA, Keaney JF: Hormone replacement therapy and endothelial function: the exception that proves the rule?. Arterioscler Thromb Vasc Biol. 2001, 21: 1867-1869.
CAS
PubMed
Google Scholar
, : Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention study (WOSCOPS). Circulation. 97 (15): 1440-1445. 1998 Apr 21,
Smith GD, Shipley MJ, Marmot MG, Rose G: Plasma cholesterol concentration and mortality. The Whitehall Study. J Am Med Assoc. 267 (1): 70-6. 10.1001/jama.267.1.70. 1992 Jan 1,
Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, Selwyn AP: Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 26: 1235-1241. 1995 Nov 1,
Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R, : Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 39 (2): 257-65. 2002 Jan 16,
Lieberman EH, Gerhard MD, Uehata A, Selwyn AP, Ganz P, Yeung AC, Creager MA: Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease. Am J Cardiol. 78 (11): 1210-4. 1996 Dec 1,
Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992, 340: 1111-1115.
Article
CAS
PubMed
Google Scholar
Eleuteri E: Comparative study of the effect of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study]. Ital Heart J Suppl. 2000, 1 (6): 830-831.
CAS
PubMed
Google Scholar
Mancini GB, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG, Wargovich TJ, Mudra H, Lüscher TF, Klibaner MI, Haber HE, Uprichard AC, Pepine CJ, Pitt B: Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation. 94 (3): 258-265. 1996 Aug 1,
Husain S, Andrews NP, Mulcahy D, Panza JA, Quyyumi AA: Aspirin improves endothelial dysfunction in atherosclerosis. Circulation. 97 (8): 716-720. ,
Brown BG, Zhao XQ, Sacco DE, Albers JJ: Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease. Circulation. 1993, 87 (6): 1781-1791.
Article
CAS
PubMed
Google Scholar
Lücher TF, Richard V, Tschudi M, Yang ZH, Boulanger C: Endothelial control of vascular tone in large and small coronary arteries. J Am Coll Cardiol. 15 (3): 519-27. 1990 Mar 1,
Chowienczyk PJ, Watts GF, Cockcroft JR, Brett SE, Ritter JM: Sex differences in endothelial function in normal and hypercholesterolaemic subjects. Lancet. 344: 305-306. 1994 Jul 30,
Susekov AV, Rozhkova TA, Tripoten' MI, Pogorelova OA, Kulev BD, Balakhonova TV, Zubareva MIu, Masenko VP, Rogozova AN, Kukharchuk VV: Randomized FARVATER study. Effect of atorvastatin on endothelial function, distensibility and stiffness of vascular wall. Kardiologiia. 2007, 47 (2): 25-30.
CAS
PubMed
Google Scholar
Martinez-González J, Badimon L: Influence of statin use on endothelial function: from bench to clinics. Curr Pharm Des. 2007, 13 (17): 1771-86.
Article
PubMed
Google Scholar
Zeiher AM, Drexler H, Wollschläger H, Just H: Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991, 83 (2): 391-401.
Article
CAS
PubMed
Google Scholar
Zeiher AM, Drexler H, Saurbier B, Just H: Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest. 1993, 92 (2): 652-662.
Article
CAS
PubMed
PubMed Central
Google Scholar
van Boven AJ, Jukema JW, Zwinderman AH, Crijns HJ, Lie KI, Bruschke AV: Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group Circulation. 94 (7): 1503-1505. 1996 Oct 1,
Tzivoni D, Klein J: Improvement of myocardial ischemia by lipid lowering drugs. Eur Heart J. 1998, 19 (2): 230-234.
Article
CAS
PubMed
Google Scholar
Bellosta S, Bernini F, Ferri N, Quarato P, Canavesi M, Arnaboldi L, Fumagalli R, Paoletti R, Corsini A: Direct vascular effects of HMG-CoA reductase inhibitors. Atherosclerosis. 1998, 137 (Suppl): S101-9.
Article
CAS
PubMed
Google Scholar
Eichstädt HW, Eskötter H, Hoffman I, Amthauer HW, Weidinger G: Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease. Am J Cardiol. 76 (2): 122A-125A. 1995 Jul 13,
O'Driscoll G, Green D, Taylor RR: Simvastatin, an HMG-coenzyme A reductase inhibitör, improves endothelial function within 1 month. Circulation. 95 (5): 1126-1131. 1997 Mar 4,
Dupuis J, Tardif JC, Cemacek P, Theroux P: Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes – The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. Circulation. 1999, 99: 3227-3233.
Article
CAS
PubMed
Google Scholar
Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P: The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 332 (8): 488-93. 1995 Feb 23,
Laufs U, Wassmann S, Hilgers S, Ribaudo N, Böhm M, Nickenig G: Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men. Am J Cardiol. 88 (11): 1306-7. 2001 Dec 1,